Please provide your email address to receive an email when new articles are posted on . Compared with married people, unmarried people were more likely to have a prolonged QT interval, according to ...

SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., July 7, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today ...

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: ...

(HealthDay News) — Use of a computerized clinical decision support system (CDSS) may reduce the risk of prolonged QT c interval in hospitalized patients at risk for torsades de pointes, according to ...

February 4, 2010 (Washington, DC) — A profoundly simple test that takes advantage of the brief heart-rate acceleration that occurs when one stands up, especially if it's done quickly, could ...

SAN FRANCISCO, CA—Consuming a large quantity of grapefruit juice has effects on the QT interval in healthy adults similar to those seen with moxifloxacin, an antibiotic with known QT-prolonging ...

Plausible explanations for differences in the prognostic impact of prolonged QTc interval among the studies are the occurrence of chance, bias and uncontrolled confounding variables. Chance could have ...

Aim To determine factors affecting the QT interval in athletes and find an improved means of QT correction (QTc) Method Data was gathered from the CAYA (Cardiovascular Assessment in Young Athletes) ...

Results to be Included in BYDUREON TM New Drug Application Resubmission in the Third Quarter of 2011 SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)--Amylin Pharmaceuticals, Inc. (Nasdaq: ...

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: ...

Results to be Included in BYDUREON™ New Drug Application Resubmission in the Third Quarter of 2011 SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)-- Amylin Pharmaceuticals, Inc. (Nasdaq: ...